You have 9 free searches left this month | for more free features.

Condition

Schizophrenia (4)

Anxiety Disorders (1)

Dementia (1)

Depression (1)

Psychosomatic Disorders (1)

Schizoaffective Disorders (1)

Schizophrenia and Disorders With Psychotic Features (1)

Overall Status

Completed (2)

Terminated (2)

Sign in for free

Phase

phase 4 (2)

phase 2 (1)

phase 3 (1)

Sponsor

Hannover Medical School (1)

Janssen Research & Development, LLC (1)

RWTH Aachen University (1)

Technical University of Munich (1)

Collaborator

Study Documents

Intervention Type

drug (4)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (4)

Benperidol

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Schizophrenia Trial in Germany (Maintenance treatment, Intermittent treatment)

Terminated

Schizophrenia

Maintenance treatment
Intermittent treatment

Aachen, NRW, Germany
+10 more

Nov 23, 2020

Schizophrenia, Schizophrenia and Disorders With Psychotic Features, Schizoaffective Disorders Trial in Munich (Olanzapine,

Completed

Schizophrenia
+2 more

Olanzapine
+18 more

Munich, Bavaria, Germany

Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psycho

Oct 10, 2018

Dementia, Depression, Schizophrenia Trial in Germany (Phenobarbital, Phenytoin, Carbamazepine)

Terminated

Dementia
+4 more

Phenobarbital
+96 more

Augsburg, Germany
+4 more

Feb 27, 2018

Schizophrenia Trial in Worldwide (JNJ-40411813, Placebo, Antipsychotic medication)

Completed

Schizophrenia

JNJ-40411813
+2 more

Innsbruck, Austria
+19 more

May 22, 2014